Cargando…
Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
Alzheimer’s disease (AD) is the most common type of dementia, and no disease-modifying treatments are available to halt or slow its progression. Amyloid-beta (Aβ) is suggested to play a pivotal role in the pathogenesis of AD, and clearance of Aβ from the brain becomes a main therapeutic strategy for...
Autores principales: | Cheng, Yuan, Tian, Ding-Yuan, Wang, Yan-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204069/ https://www.ncbi.nlm.nih.gov/pubmed/32381118 http://dx.doi.org/10.1186/s40035-020-00195-1 |
Ejemplares similares
-
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease
por: Chachaj, Angelika, et al.
Publicado: (2023) -
Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer’s Disease From the Perspective of Pathophysiological Processes
por: Zeng, Peng, et al.
Publicado: (2021) -
Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020) -
Physiological clearance of Aβ by spleen and splenectomy aggravates Alzheimer‐type pathogenesis
por: Yu, Zhong‐Yuan, et al.
Publicado: (2021) -
Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)